title: Leucine kinetics and the effects of hyperinsulinemia in patients with Cushing's syndrome.
abstract: As muscle wasting and resistance to insulin-mediated glucose utilization are features of Cushing's syndrome (CS), we examined glucose and amino acid metabolism in six patients with CS and six normal subjects before and during euglycemic hyperinsulinemic clamp studies (plasma insulin concentrations, approximately 0.36, approximately 0.65, and approximately 10.05 mmol/L). The two groups had similar body mass index values. In the postabsorptive state, leucine and alpha-ketoisocaproate (KIC) rates of appearance (Ra), KIC oxidation, and nonoxidized leucine-carbon flux, an index of leucine entering protein (Leu----P), were comparable in CS patients [2.38 +/- 0.14 (+/- SE), 0.22 +/- 0.04, and 2.16 +/- 0.12 mumol/kg.min) and in normal subjects (2.73 +/- 0.25, 0.17 +/- 0.02, and 2.59 +/- 0.22 mumol/kg.min). During the euglycemic clamp studies the leucine and KIC Ra values, KIC oxidation, and Leu----P decreased to a similar extent in both groups. In contrast, insulin-mediated glucose utilization was impaired in the CS patients at each clamp step (P less than 0.05). In summary, postabsorptive whole body leucine metabolism is normal in patients with CS and is normally suppressed by hyperinsulinemia, indicating a dissociation in insulin sensitivity with respect to glucose and amino acid metabolism.
authors.affiliation: Cattedra di Malattie del Ricambio, University of Padova, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Tessari
authors.forename: S
authors.initials: S
authors.lastname: Inchiostro
authors.forename: G
authors.initials: G
authors.lastname: Biolo
authors.forename: M C
authors.initials: MC
authors.lastname: Marescotti
authors.forename: G
authors.initials: G
authors.lastname: Fantin
authors.forename: M T
authors.initials: MT
authors.lastname: Boscarato
authors.forename: G
authors.initials: G
authors.lastname: Merola
authors.forename: F
authors.initials: F
authors.lastname: Mantero
authors.forename: A
authors.initials: A
authors.lastname: Tiengo
mesh_terms: D000293:Adolescent; D000328:Adult; D000596:Amino Acids / Q000097:blood; D001786:Blood Glucose / Q000032:analysis / Q000378:metabolism; D003480:Cushing Syndrome / Q000378:metabolism* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood / Q000494:pharmacology*; D007333:Insulin Resistance; D007651:Keto Acids / Q000097:blood; D007700:Kinetics; D007930:Leucine / Q000378:metabolism*; D008297:Male; D008875:Middle Aged
chemical_list: D000596:Amino Acids; D001786:Blood Glucose; D007328:Insulin; D007651:Keto Acids; C013082:alpha-ketoisocaproic acid; D007930:Leucine